immunoMUSE® enables flexible, high-sensitivity multiplex immunofluorescence with user-defined antibodies. Schlieren, Switzerland – arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services. Through this partnership, Europa Biosite will distribute arcoris bio’s newly launched immunoMUSE® kits in [...]

Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md. -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced that it has entered into a technology license partnership [...]

Backed by KKR’s £4.7 billion acquisition of Malvern Panalytical parent company Spectris, the materials characterization leader enters a new era of innovation, customer focus, and long-term ambition. Malvern, UK, Sciad Communications -- Malvern Panalytical is setting an ambitious new course for growth, with Christian Sauber, Ph.D., as President and following the acquisition of its parent company Spectris [...]

Partnership combines Sirona Dx‘s technology-agnostic spatial biology expertise with Parhelia‘s Spatial Station platform to improve reproducibility, increase throughput, and reduce costs across spatial biology workflows. ASHLAND, Ore. and PORTLAND, Ore. — Parhelia Biosciences and Sirona Dx today announced a strategic partnership aimed at advancing the adoption of spatial biology in translational research, clinical trials, and precision health [...]

TUCSON, Ariz. -- Clinisys, a global leader in laboratory informatics, today announced the general availability of Clinisys™ Laboratory Solution (CLS) v2025.3, continuing the evolution of its unified platform for scientific and healthcare laboratories. The release extends CLS with enhanced configuration, expanded interoperability, integrated analytics, and governed AI capabilities—helping laboratories simplify operations, improve visibility, and scale [...]

Milestone Reflects Deepening Customer Centricity as DNAnexus Continues to Scale its Platform for the World's Leading Life Sciences Organizations, Accelerating Growth By Global Expansion MOUNTAIN VIEW, Calif. -- Today, DNAnexus, the world's most trusted platform for omics data enablement, announced it has achieved a 90% customer satisfaction score (CSAT) — a milestone underscoring the trust [...]

Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts Includes headline Phase 1 monotherapy data for TLN-121 in relapsed or refractory lymphomas with overall response rate of 84%, complete response rate of 32% and no [...]

Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS [...]

Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use Signals environments and modality-specific workflows Scalable informatics foundation that supports growth, collaboration and investor readiness WALTHAM, Mass. — Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt [...]

Validation of HALO's Advanced Security Screening Technology Agilent Technologies, Inc. has led a multimillion dollar investment round in which other existing Blue Chip investors UK Innovation Science Seed Fund (UKI2S) and the Midland Engine Investment Fund (MEIF) also participated. The investment enables HALO to complete regulatory approval of its advanced security screening technology ahead of [...]